厂家供应原料药达比加群酯 ,211915-06-9
英文名称:N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester
英文别名:Pradaxa; Dabigatran etexilate; BIBR-1048MS; BIBR-1048; ethyl N-[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate; Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester
CAS号:211915-06-9
化学名称:β-丙氨酸,N-[[2-[[[4-[[[(己氧基)羰基]氨基]亚氨基甲基]苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-嘧啶-,乙酯,甲磺酸盐
分子量:723.86 (甲磺酸盐)
627.75 (游离物)
预防存在以下一个或多个危险因素的成人非瓣膜性房颤患者的卒中和全身性栓塞(SEE):
● 先前曾有卒中、短暂性脑缺血发作或全身性栓塞
● 左心室射血分数<40%
●伴有症状的心力衰竭,纽约心脏病协会(NYHA)心功能分级≥2级
●年龄≥75岁
●年龄≥65岁,且伴有以下任一疾病:糖尿病、冠心病或高血压
密度:1.24g/cm3
沸点:827.9°C at 760 mmHg
闪点:454.5°C